BASF’s Triple Catalyst: China Plant Beats Expectations, Coatings Deal Closes, and Agri Spinoff Gathers Steam

BASF shares climb 4.34% in a week on coatings divestment completion, Zhanjiang plant ramp-up ahead of schedule, and planned €20-30bn agricultural IPO.

Shares in BASF extended a seven-day winning streak on Tuesday, adding 1.73% in intraday trade and touching €49.45 before settling at €49.33. The stock has now gained 4.34% over the past week and sits roughly 10.5% higher year to date. The rally reflects a confluence of three distinct catalysts: the completion of the coatings divestment, a faster-than-expected ramp-up at the new Chinese megaproject, and fresh momentum behind the planned partial listing of the agricultural business.

BASF confirmed on Tuesday that the sale of its Coatings division to private equity firm Carlyle closed on June 30, 2026. The deal bolsters the group’s balance sheet and provides financial headroom for the ongoing portfolio transformation. Under the stewardship of CEO Markus Kamieth, BASF is shedding non-core assets to concentrate capital on specialty chemicals and Asian growth markets. “The coatings exit is a clear sign that management is executing its strategy with discipline,” one market watcher noted.

Equally significant is the progress at the company’s integrated Verbund site in Zhanjiang, China. Inaugurated only in March 2026 at a cost of €8.7 billion, the facility is approaching operating breakeven some 100 days after startup – well ahead of schedule. The plant runs entirely on renewable electricity and positions BASF to capture rising Asian demand while reducing the group’s exposure to volatile European energy costs. Media reports also indicate that the project was delivered under budget, a further fillip for cost-conscious investors.

The largest strategic catalyst, however, remains the planned initial public offering of BASF’s Agricultural Solutions division. Shareholders approved the carve-out at the annual general meeting in April 2026, and the company is targeting a listing in the second quarter of 2027. Valuations for the agri business are widely estimated at between €20 billion and €30 billion. To put that in perspective, BASF’s current market capitalisation stands at €42.05 billion, meaning the spinoff alone could represent roughly 71% of the group’s present value. The division posted revenues of €9.6 billion in 2025 with an Ebitda margin north of 20%. Management is pursuing a dual-track approach, keeping the option open for a direct sale of a minority stake should market conditions for an IPO sour.

Bullish analysts argue that the spinoff could force a re-rating of BASF’s shares by shrinking the conglomerate discount that has long dogged the stock. Competitor Corteva, for example, commands a significantly higher Ebitda multiple. Should the Zhanjiang plant’s cost advantage translate into better margins, the case for a higher valuation strengthens further. Yet the bears warn that regulatory headwinds – notably the EU’s methane regulation, due to take effect in 2027, and bureaucratic obstacles to the hydrogen economy – could crimp profitability at European sites. Moreover, Brent crude at $85 a barrel may boost pricing power in the short term but risks compressing chemical margins if raw-material costs rise faster than selling prices.

Technically, the stock has broken decisively above the 200-day moving average of €47.51, which now offers a solid support base. The 50-day moving average at €49.85 poses the next resistance level, lying less than 1% above Tuesday’s closing price. The relative strength index (RSI) at 57 suggests there is room for further gains before the stock becomes overbought. A sustained break above the 50-day line could open the path toward the 52-week high of €55.05. Conversely, failure to hold the 200-day support might lead to a retest of the 52-week low at €41.60, particularly if global economic data disappoints.

All eyes now turn to the half-year financial report, due on July 29, 2026. Investors will scrutinise free cash flow and margins in the Chemicals segment, looking for evidence that the cost-cutting programmes are bearing fruit. Analysts project a full-year dividend of approximately €2.28 per share. The earnings release will also test whether the agri-spinoff narrative has enough operational substance to sustain the current upward momentum or whether lingering macroeconomic risks will force a pullback.